ESCVS social:






Congress Program

20 may, 2011. Friday
1st Congress Day
15:30 - 16:30
C4: MISCELLANEA II
Moderators: G. Bisleri (Italy), N. Shikhverdiyev (Russian Federation)

C4-1
IMPLANTATION OF CAVA FILTER AS A PREVENTION METHOD OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH EMBOLEGENIC DEEP VEIN THROMBOSIS OF LOWER EXTREMITIES
A. Bocharov, A. Ukhanov (Russian Federation)

C4-2
EFFICACY OF LEVOSEMINDAN PRETREATMENT IN HIGH-RISK CARDIAC SURGERY PATIENTS
A. Bautin (Russian Federation)

C4-3
MORTALITY RISK STRATIFICATION AND TREATMENT MONITORING IN JEHOVAH'S WITNESS PATIENTS WITH SEVERE ANAEMIA
A. Beliaev, R. Marshall, W. Smith, J. Windsor (New Zealand)

C4-4
HIGH-RISK PULMONARY THROBOEMBOLISM: PRACTICAL APPROACH TO COMPLEX TREATMENT
A. Medvedev, V. Pichugin, S. Nemirova, S. Jourko, N. Melnikov, A. Bogush, V. Prytkov (Russian Federation)

C4-5
A NOVEL SURGICAL-PERFUSIONAL TECHNIQUE FOR THE TREATMENT OF RENAL CANCER EXTENDING INTO THE HEART
G. Bisleri, A. Moggi, S. Cosciani, A. Antonelli, F.H. Cheema, C. Muneretto (Italy)

C4-6
IS A SINGLE-STEP SURGICAL TREATMENT OF CORONARY ARTERY DISEASE AND ANEURISMAL DISEASE OF THORACOABDOMINAL AORTA JUSTIFIED?
R. Komarov, Yu. Belov, A. Stepanenko, A. Gens, N. Stogny (Russian Federation)

C4-7
THREE YEARS AFTER APROTININ'S WITHDRAWAL. WAS IT A CORRECT DECISION?
A. Paschalis, S. Datta, A. Steit, Y. Nasher, F. Hashmi, B. O’Neill, T. Velissaris, R. Hasan (UK)


Platinum Partners



Gold Partner



Technical Partner